{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:40:03Z","timestamp":1784860803278,"version":"3.55.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\ufffdd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In 2009, a new influenza A H1N1 virus emerged causing a global pandemic. A range of monovalent influenza A H1N1pdm09 vaccines with or without adjuvants were developed. After the mass vaccination campaigns safety concerns related to H1N1pdm09 vaccines were reported. More than a decade later, reported AEFIs are still under scrutiny. We performed a systematic review aiming to synthesize the evidence on the safety of the H1N1pdm09 vaccines on reported outcomes from existing systematic reviews.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Four electronic databases, PubMed, EMBASE, Epistimonikos and the Cochrane Database of Systematic Reviews were searched for articles on H1N1pdm09 vaccination published from 2009 to January 2021. Systematic reviews assessing short- or long-term adverse events after H1N1pdm09 vaccination were considered for inclusion. Data was extracted from all selected reviews. Outcomes were grouped and results from each included review were presented narratively and in tables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>16 systematic reviews met the inclusion criteria. Reported outcomes were short-term events (3 reviews), fetal\/pregnancy outcomes (8 reviews), Guillain-Barr\u00e9 syndrome (GBS) (4 reviews), narcolepsy (2 reviews) demyelinating diseases (1 review based on one study only) and inflammatory bowel disease (IBD) (1 review). Short-term serious adverse events were rare, 3 cases amongst 16725 subjects in 18 randomized controlled trials (0.018%). No deaths were reported. The risks of local events were generally higher for adjuvanted vaccines as compared to unadjuvanted vaccines. Maternal H1N1pdm09 vaccination in any trimester was not associated with an increase in preterm birth, small for gestational age, congenital malformations or fetal death. For GBS, results were conflicting. The main systematic review on narcolepsy found a 5-14-fold increased risk in children, and a 2-7- fold increased risk in adults after vaccination with Pandemrix. The attributable risk of narcolepsy one year after vaccination was 1 case per 18 400 vaccine doses in children\/adolescents, and 1 case per 181 000 vaccine doses in adults.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Adjuvanted vaccines had more local but not serious adverse events compared to unadjuvanted vaccines. Vaccination with Pandemrix was strongly associated with narcolepsy, particularly in children. No increased risks of pregnancy outcomes were seen after pandemic vaccination. The findings on GBS were inconclusive.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.740048","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T09:25:30Z","timestamp":1635413130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews"],"prefix":"10.3389","volume":"12","author":[{"given":"Lene Kristine","family":"Juvet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Hayman","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Laake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Mjaaland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lill","family":"Trogstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"B1","unstructured":"Centers for Disease Control and Prevention (CDC)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of Global Seasonal Influenza-Associated Respiratory Mortality: A Modelling Study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"c1279","DOI":"10.1136\/bmj.c1279","article-title":"Critical Illness Due to 2009 A\/H1N1 Influenza in Pregnant and Postpartum Women: Population Based Cohort Study","volume":"340","year":"2010","journal-title":"BMJ"},{"key":"B4","unstructured":"New Data on Narcolepsy Following the 2009 Pandemic Influenza VaccineThe Global Advisory Comittee of Vaccine Safety2017"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.005","article-title":"Safety Monitoring of Influenza A\/H1N1 Pandemic Vaccines in EudraVigilance","volume":"29","author":"Kurz","year":"2011","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.vaccine.2017.02.059","article-title":"Effectiveness of 2009 Pandemic Influenza A(H1N1) Vaccines: A Systematic Review and Meta-Analysis","volume":"35","author":"Lansbury","year":"2017","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"pii=30208","DOI":"10.2807\/1560-7917.ES.2016.21.16.30208","article-title":"Pandemic Vaccination Strategies and Influenza Severe Outcomes During the Influenza A(H1N1)pdm09 Pandemic and the Post-Pandemic Influenza Season: The Nordic Experience","volume":"21","author":"Gil Cuesta","year":"2016","journal-title":"Euro Surveill"},{"key":"B8","volume-title":"Causality Assessment of an Adverse Event Following Immunization (AEFI): User Manual for the Revised WHO Classification 2nd Ed., 2019 Update","year":"2019"},{"key":"B9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10654-015-0047-0","article-title":"Risk of Guillain-Barr\u00e9 Syndrome After Exposure to Pandemic Influenza A(H1N1)pdm09 Vaccination or Infection: A Norwegian Population-Based Cohort Study","volume":"31","author":"Ghaderi","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.018","article-title":"Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME) is Associated With Pandemic Influenza Infection, But Not With an Adjuvanted Pandemic Influenza Vaccine","volume":"33","author":"Magnus","year":"2015","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 Adjuvanted AH1N1 Vaccine Associated With an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31828ab26f","article-title":"Increased Childhood Incidence of Narcolepsy in Western Sweden After H1N1 Influenza Vaccination","volume":"80","author":"Szakacs","year":"2013","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.02.053","article-title":"Narcolepsy and Hypersomnia in Norwegian Children and Young Adults Following the Influenza A(H1N1) 2009 Pandemic","volume":"35","author":"Trogstad","year":"2017","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of Narcolepsy in Children and Young People Receiving AS03 Adjuvanted Pandemic A\/H1N1 2009 Influenza Vaccine: Retrospective Analysis","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"d3908","DOI":"10.1136\/bmj.d3908","article-title":"Guillain-Barre Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccine: Multinational Case-Control Study in Europe","volume":"343","author":"Dieleman","year":"2011","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 Statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: Elaboration and Explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"B18","unstructured":"Rayyan"},{"key":"B19","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: A Critical Appraisal Tool for Systematic Reviews That Include Randomised or non-Randomised Studies of Healthcare Interventions, or Both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"Cd004876","DOI":"10.1002\/14651858.CD004876.pub4","article-title":"Vaccines for Preventing Influenza in the Elderly","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.11124\/jbisrir-2014-1269","article-title":"Influenza Vaccination During Pregnancy: A Systematic Review of Effectiveness and Safety","volume":"12","author":"McMillan","year":"2014","journal-title":"JBI Database Syst Rev Implement Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/1471-0528.12977","article-title":"Fetal Death and Preterm Birth Associated With Maternal Influenza Vaccination: Systematic Review","volume":"122","author":"Fell","year":"2015","journal-title":"Bjog"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0375","article-title":"Early Childhood Health Outcomes Following In Utero Exposure to Influenza Vaccines: A Systematic Review","volume":"146","author":"Foo","year":"2020","journal-title":"Pediatrics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1540807","article-title":"The Safety of Inactivated Influenza Vaccines in Pregnancy for Birth Outcomes: A Systematic Review","volume":"15","author":"Giles","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.06.039","article-title":"An Indirect Comparison Meta-Analysis of AS03 and MF59 Adjuvants in Pandemic Influenza A(H1N1)pdm09 Vaccines","volume":"37","author":"Hauser","year":"2019","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e24384","DOI":"10.1371\/journal.pone.0024384","article-title":"Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines","volume":"6","author":"Manzoli","year":"2011","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain-Barre Syndrome and Influenza Vaccines: A Meta-Analysis","volume":"33","author":"Martin Arias","year":"2015","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1586101","article-title":"The Effects of Influenza Vaccination During Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis","volume":"33","author":"Nunes","year":"2016","journal-title":"Am J Perinatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.04.179","article-title":"Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies","volume":"13","author":"Pineton de Chambrun","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001068","article-title":"Maternal Influenza Vaccination and Risk for Congenital Malformations a Systematic Review and Meta-Analysis","volume":"126","author":"Polyzos","year":"2015","journal-title":"Obstet Gynecol"},{"key":"B31","article-title":"Guillain-Barre Syndrome and Influenza Vaccines: Current Evidence","volume":"32","author":"Sanz Fadrique","year":"2019","journal-title":"Rev Esp Quimioter"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of Narcolepsy After H1N1 Influenza and Vaccinations: Systematic Review and Meta-Analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.024","article-title":"A Systematic Review and Meta-Analysis on the Safety of Newly Adjuvanted Vaccines Among Children","volume":"34","author":"Stassijns","year":"2016","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13181","article-title":"Systematic Review of Factors Associated With the Development of Guillain-Barr\u00e9 Syndrome 2007-2017: What has Changed","volume":"24","author":"Wachira","year":"2019","journal-title":"Trop Med Int Health"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12394","article-title":"A Systematic Review and Meta-Analysis of Fetal Outcomes Following the Administration of Influenza A\/H1N1 Vaccination During Pregnancy","volume":"141","author":"Zhang","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e108489","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of Narcolepsy Associated With Inactivated Adjuvanted (AS03) A\/H1N1 (2009) Pandemic Influenza Vaccine in Quebec","volume":"9","author":"Montplaisir","year":"2014","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.23799","article-title":"Decreased Incidence of Childhood Narcolepsy 2 Years After the 2009 H1N1 Winter Flu Pandemic","volume":"73","author":"Han","year":"2013","journal-title":"Ann Neurol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy Onset is Seasonal and Increased Following the 2009 H1N1 Pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbi.2014.11.004","article-title":"Comparison of Pandemrix and Arepanrix, Two Ph1n1 AS03-Adjuvanted Vaccines Differentially Associated With Narcolepsy Development","volume":"47","author":"Jacob","year":"2015","journal-title":"Brain Behav Immun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"E12323","DOI":"10.1073\/pnas.1818150116","article-title":"Autoimmunity to Hypocretin and Molecular Mimicry to Flu in Type 1 Narcolepsy","volume":"115","author":"Luo","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e114361","DOI":"10.1371\/journal.pone.0114361","article-title":"Antigenic Differences Between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk","volume":"9","author":"Vaarala","year":"2014","journal-title":"PloS One"},{"key":"B42","article-title":"Pandemic Influenza A (H1N1) 2009 Virus Vaccine - Conclusions and Recommendations From the October 2009 Meeting of the Immunization Strategic Advisory Group of Experts","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"B43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-018-0695-8","article-title":"An Introduction to Overviews of Reviews: Planning a Relevant Research Question and Objective for an Overview","volume":"7","author":"Hunt","year":"2018","journal-title":"Syst Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13643-016-0347-9","article-title":"Use of Existing Systematic Reviews for Evidence Assessments in Infectious Disease Prevention: A Comparative Case Study","volume":"5","author":"Harder","year":"2016","journal-title":"Syst Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"i157","DOI":"10.1136\/bmj.i157","article-title":"PRISMA Harms Checklist: Improving Harms Reporting in Systematic Reviews","volume":"352","author":"Zorzela","year":"2016","journal-title":"BMJ"},{"key":"B46","unstructured":"Report of the Review Committee on the Functioning of the International Health Regulations (2005) in Relation to Pandemic (H1N1) 2009WHO 2011; SIXTY-FOURTH WORLD HEALTH ASSEMBLY2005"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01433-3","article-title":"Long COVID in a Prospective Cohort of Home-Isolated Patients","volume":"27","author":"Blomberg","year":"2021","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00085-4","article-title":"The European Medicines Agency\u2019s EU Conditional Marketing Authorisations for COVID-19 Vaccines","volume":"397","author":"Cavaleri","year":"2021","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2139\/ssrn.3812422","article-title":"Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"9","author":"Pormohammad","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia After ChAdOx1 Ncov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.7637","article-title":"Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine","volume":"325","author":"Karron","year":"2021","journal-title":"JAMA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia After ChAdOx1 Ncov-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.740048\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T09:25:38Z","timestamp":1635413138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.740048\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2021.740048"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.740048","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"article-number":"740048"}}